Skip to main content
. Author manuscript; available in PMC: 2019 Feb 8.
Published in final edited form as: J Med Chem. 2018 Jan 5;61(3):1182–1203. doi: 10.1021/acs.jmedchem.7b01654

Table 4.

SAR of meta aniline ring substitutions

graphic file with name nihms967105u5.jpg
Compound R2 R4 Tb IC50,b μM Hs IC50,c μM Tb427 EC50,d μM
7 Cl Cl 3.7 (3.3–4.1) 27% at 180 5.6 (4.5–7.1)
32 Br Cl 2.2 (2.0–2.4) 33% at 180 4.7 (3.9–5.8)
33 CN Cl 3.9 (3.2–4.8) 29% at 180 12 (10–14)
34 CF3 Cl 3.9 (3.4–4.4) 39% at 180 13 (11–15)
35 Ph Cl 3.3 (2.8–3.9) 30% at 63 4.5 (2.1–9.4)
36 SF5 Cl 16 (14–18) >180 13 (11–15)
37 SF5 Br 8.7 (7.4–10) >180 0.45 (0.32–0.62)
38 Et Br 7.6 (5.7–10) >180 5.5 (4.6–6.6)
39 OEt Br 6.0 (5.2–6.9) 36% at 180 4.4 (4.2–4.7)
40 OCH2CF3 Br 1.6 (1.1–2.4) 44 4.2 (3.6–4.8)
41 OCH2CHCH2 Br 4.5 (4.1–4.9) 28% at 180 4.4 (3.7–5.3)
42 OBu Br 4.5 (4.0–5.1) >180 1.9 (1.7–2.1)
43 OCH2iPr Br 11 (9.5–12) >180 4.4 (3.5–5.5)
44 Br Br 1.9 (1.7–2.1) 31% at 180 4.8 (4.1–5.6)
45 SO2Me SO2Me 1.5 (1.3–1.7) 39% at 180 >100
46 CF3 CF3 11 (9.8–12) >180 14 (11–17)
47 OMe OMe 17 (14–20) 21% at 180 41 (33–51)
48 CO2H CO2H >180 >180 >100
49 CO2Me CO2Me 40% at 180 >180 42 (22–78)
50 Ph Ph >180 >180 1.5 (1.3–1.6)
51 N-(3,5-Cl2Ph)−acetamide N-(3,5-Cl2Ph)−acetamide >180 >180 2.0 (1.2–3.7)
52 Me Me 141 (119–167) >180 19 (17–22)
53 tBu tBu >63 >63 4.1 (4.1–4.5)
54 SF5 H 23% at 180 >180 14 (11–17)
55 Cl H 35% at 180 >180 42 (34–52)
56 Br H 41% at 180 >180 22 (19–26)
57 F H >180 >180 >25
58 SMe H 149 (122–181) 23% at 180 >25
59 H H >180 >180 >25
60 F F 180 (160–201) >180 70 (61–80)
61 F Cl 32 (13–82) >180 17 (15–20)

All compounds have pKa(N1)a of 7.3.

a, b, c, d

See footnotes for Table 1.